Incyte stock drops as BMO cuts on buybacks (NASDAQ:INCY)
Pgiam/iStock via Getty Images Shares of Incyte (NASDAQ:INCY) traded lower on Tuesday after BMO Capital Markets downgraded the drugmaker to underperform from market perform, citing the potential consequences of the company’s recently announced $2B share buybacks. The transaction targeted for up to $1.672B worth of Incyte’s (INCY) common stock “appearsContinue Reading